Replies to post #661 on Genprex Inc (GNPX)

[Hercules1]

$GNPX:



agreed. it is going to bounce back strong this coming week.



should close out the week around $2.50 to $3.

[TommyBoyTrader9460]

Target Activity
Our cancer gene therapy platform and its innovative delivery system are highly targeted. While the TUSC2 gene induces apoptosis in cancer cells which have low or absent TUSC2 expression, TUSC2 delivered by nanovesicles to normal cells is well tolerated relative to other lung cancer drugs. Moreover, the nanovesicles are taken up by tumor cells after Oncoprex treatment at 10 to 25 times the rate at which they are taken up by normal cells, due to selective endocytosis of the nanovesicle lipid formulation and the enhanced permeability and retention, or EPR, characteristics of tumor vasculature, without the need for external ligands, or binding molecules.

$gnpx